Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-α2

This publication has 36 references indexed in Scilit:

• Effects of interferon‐α on human b cells: Repression of apoptosis and prevention of cell growth are independent responses of burkitt lymphoma lines
  International Journal of Cancer, 1995
• The Fas Death Factor
  Science, 1995
• Interleukin-6 prevents dexamethasone-induced myeloma cell death
  Blood, 1994
• Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein.
  Journal of Clinical Investigation, 1994
• Differential regulation of interleukin-6 receptors by interleukin-6 and interferons in multiple myeloma cell lines
  European Journal of Immunology, 1994
• Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family
  Cell, 1993
• Interferon alfa-2b with VMCP compared to VMCP alone for induction and interferon alfa-2b compared to controls for remission maintenance in multiple myeloma: Interim results
  European Journal of Cancer and Clinical Oncology, 1991
• Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy
  New England Journal of Medicine, 1990
• Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
  Science, 1989
• A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.
  The Journal of Experimental Medicine, 1989